Doxorubicin,Bleomycin,vinblastine,Dacarbazine
not tagged
['cml']
#17icml plenary session. dr. pinto presented abvd pet adapted vs. abvd dd di (doxorrubicine 35mg/m2 d1 and d11). favoring abvd dd di, hr 0.44 ci95% 0.28-0.67. pfs 35m 86.7% with abvd petadapted. delta =13.46%. 
Happily married. Hematologist & SC Transplanter. field of interest: lymphoma-myeloma &chemoresistance biomarkers. @HematoClinicBCN @hematosantpau.@GELL01433166